Publications by authors named "Edith Perez"

Claim this Profile
C
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.
Irene M Kang, Jamie K Forschmiedt, Michelle M Loch, Danika L Lew, William E Barlow, Edith A Perez

JAMA Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Proposed highway in the Peruvian Amazon threatens vulnerable indigenous communities and natural protected areas.
Brian M Griffiths, David Dimitrie, Elizabeth Schierbeek, Edith Chinchilla Perez, Ellen Nirenblatt

Ambio· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, John M S Bartlett, Tammy Piper, Edith A Perez

Breast Cancer Res Treat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed highway in the Peruvian Amazon threatens vulnerable indigenous communities and natural protected areas.
Brian M Griffiths, David Dimitrie, Elizabeth Schierbeek, Edith Chinchilla Perez, Ellen Nirenblatt

Ambio· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.
Yara Abdou, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain, Edith A Perez

J Natl Cancer Inst· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.
Saranya Chumsri, Joseph J Larson, Emily Liu, Kathleen S Tenner, Daniel Adams, Edith A Perez

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.
Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter, Jennifer M Kachergus, Yaohua Ma, Edith A Perez

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.
Hesham Elghazaly, Hamdy A Azim, Hope S Rugo, David Cameron, Sandra M Swain, Edith A Perez

Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang, Edith A Perez

Breast Cancer Res Treat· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, John M S Bartlett, Tammy Piper, Edith A Perez

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor-Positive, HER2-Positive Breast Cancer.
Saranya Chumsri, Tanmayi Pai, Yaohua Ma, Zhuo Li, Angelica Gil, Edith A Perez

J Natl Compr Canc Netw· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang, Edith A Perez

Res Sq· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.
Marla Lipsyc-Sharf, Karla V Ballman, Jordan D Campbell, Hyman B Muss, Edith A Perez

JAMA Netw Open· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osseointegration of Dental Implants in Patients with Congenital and Degenerative Bone Disorders: A Literature Review.
Edith Perez, Liliana Salinas, Roman Mendoza, Maria Eugenia Guerrero, Jose Oliva

J Int Soc Prev Community Dent· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial.
Pooja P Advani, Kathryn J Ruddy, Joerg Herrmann, Jordan C Ray, Emily C Craver, Edith A Perez

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
Jodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, Yaohua Ma, Xue Wang, Edith A Perez

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era.
Stephanie L Graff, Tanya Wildes, Narjust Duma, Don S Dizon, Noelle K LoConte, Edith A Perez

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10.
Jing Yang, Changchun Hou, Huashan Wang, Edith A Perez, Hanh Chi Do-Umehara

Cancer Lett· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review.
Edith A Perez, Chau Dang, Caleb Lee, Jasmeet Singh, Kongming Wang

Breast Cancer Res Treat· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
Rafael Caparica, Yaohua Ma, Claudia De Angelis, François Richard, Christine Desmedt, Edith A Perez

Clin Breast Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.
Saranya Chumsri, Zhuo Li, Daniel J Serie, Nadine Norton, Afshin Mashadi-Hossein, Edith A Perez

NPJ Breast Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Kostandinos Sideras, David W Hillman, Karthik Giridhar, Brenda F Ginos, Richard C Tenglin, Edith A Perez

Oncologist· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK-3β Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
Marisa J Stachowski-Doll, Maria Papadaki, Thomas G Martin, Weikang Ma, Henry M Gong, Edith Perez

Circ Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.
Owen Garrick, Ruben Mesa, Andrea Ferris, Edward S Kim, Edith Mitchell, Edith Perez

Ethn Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Patricia A Ganz, Hanna Bandos, Charles E Geyer, André Robidoux, Alexander H G Paterson, Edith A Perez

Breast Cancer Res Treat· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis